Soy Isoflavones — Genistein & Daidzein (Phytoestrogens · Legume Polyphenols)
| CAS No. | 446-72-0 (Genistein) · 486-66-8 (Daidzein) |
| Class | Polyphenol · Isoflavone · Phytoestrogen · Flavonoid subclass |
| Source | Glycine max (Soybean) — seed (primary); also red clover (Trifolium pratense) as a non-soy alternative |
| Claim strength | Moderate |
| Buy from Herbuno | Daidzein Powder → |
Soybeans have been a cornerstone of East Asian food culture for over 5,000 years. Epidemiological comparisons between East Asian populations consuming traditional soy-rich diets and Western populations revealed striking differences in menopausal symptom rates, bone density trajectories, and cardiovascular disease incidence. Genistein and daidzein are the primary biologically active isoflavones responsible. They bind to oestrogen receptors with preferential affinity for ERβ. Daidzein is further converted by specific gut microbiota to equol — a more potent phytoestrogen — in approximately 30–50% of individuals, accounting for significant inter-individual variation in response.
Soy Isoflavones for Menopausal Health, Bone Density & Cardiovascular Support — Evidence
Menopausal symptom relief: Meta-analyses of RCTs document reductions in hot flush frequency and severity with soy isoflavone supplementation at 40–80mg per day — approximately 20–30% reduction versus placebo. Claim strength: Moderate.
Bone mineral density: Multiple RCTs document preservation of bone mineral density and reductions in bone resorption markers in postmenopausal women. Genistein at 54mg per day has the most robust bone density evidence. Claim strength: Moderate.
Cardiovascular support: Soy protein with isoflavones has documented effects on LDL cholesterol, arterial elasticity, and endothelial function in postmenopausal women. Claim strength: Moderate.
Soy Isoflavone Dosage, Standardisation & Formulator Specification
Clinically referenced dose: 40–80mg per day of total isoflavones (expressed as aglycone equivalents) for menopausal symptom relief. 54mg per day of genistein for bone density applications. Isoflavone content should be verified by HPLC and expressed as aglycone equivalents on the CoA.
Aglycone vs glycoside forms: Soy isoflavones naturally occur predominantly as glucoside conjugates. Fermented soy products and aglycone-enriched extracts may offer bioavailability advantages.
Phytoestrogenic activity — safety note: Standard supplement label precautions for hormone-sensitive conditions, pregnancy, and breastfeeding are mandatory.
Pairs with: Shatavari (female hormonal support), calcium and Vitamin D (bone health stack), black cohosh (menopausal symptom combination).
Frequently Asked Questions — Soy Isoflavones
What is the difference between genistein and daidzein?
Genistein has stronger oestrogen receptor binding affinity and more robust bone density evidence. Daidzein is converted by specific gut bacteria to equol — a more potent phytoestrogen — in approximately 30–50% of individuals. Equol-producer status significantly affects daidzein's clinical efficacy.
What is equol and why does it matter?
Equol is a daidzein metabolite produced by specific gut bacteria with higher ERβ binding affinity. Approximately 30–50% of Western and 50–60% of East Asian populations are equol producers — a difference that may partly explain stronger soy effects in East Asian epidemiological studies.
Are soy isoflavones safe for women with breast cancer history?
Current consensus suggests soy food at dietary levels is generally safe for breast cancer survivors. High-dose isolated isoflavone supplements require individual medical consultation. Standard phytoestrogenic precautionary label text is required.
Why does soy isoflavone efficacy vary so much between individuals?
Primary explanation is equol-producer status. Additionally, oestrogen receptor expression varies, baseline hormone levels influence competition effects, and isoflavone form (aglycone vs glycoside) affects absorption.
Claim-strength scale – High = multiple human studies; Moderate = a few trials; Emerging = early lab data.
← Back to Active Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery